DMB-I (INN: Latrepirdine) Clinical Trials

1 actively recruiting trial

Also known as: Latrepirdine, Dimebon®

Pipeline

Phase 3: 1

Top Sponsors

Bigespas LTD1

Indications

Alzheimer Type Dementia1
Alzheimer's Disease1

Other1 trial

Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.